{"organizations": [], "uuid": "6ae087893a35efdd86280041251807348b7b951e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/05/14/globe-newswire-bionovelus-first-quarter-reports.html", "country": "US", "domain_rank": 767, "title": "BIONOVELUS' FIRST QUARTER REPORTS", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-15T04:45:00.000+03:00", "replies_count": 0, "uuid": "6ae087893a35efdd86280041251807348b7b951e"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/05/14/globe-newswire-bionovelus-first-quarter-reports.html", "ord_in_thread": 0, "title": "BIONOVELUS' FIRST QUARTER REPORTS", "locations": [], "entities": {"persons": [{"name": "nathalie ekobo", "sentiment": "none"}, {"name": "anthony j. parkinson", "sentiment": "none"}], "locations": [{"name": "phoenix", "sentiment": "none"}], "organizations": [{"name": "inc.", "sentiment": "none"}, {"name": "bionovelus inc", "sentiment": "none"}, {"name": "marketing & communications", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "FOR IMMEDIATE RELEASE — Phoenix, May 14, 2018 (GLOBE NEWSWIRE) -- / BioNovelus (OTC Pink: ONOV) has published today its first quarter of 2018 financial statements and report.\nThis information is attached to this Press Release, and also available at https://bionovelus.com/quarterly-reports/\n— 30 —\nAttachments\n2018_1Q_OTCReport 1st Quarter Financials 2018 Media contact: Nathalie Ekobo, Marketing & Communications Director BioNovelus, Inc. +1 888-924-6668 ext.1 NEkobo@BioNovelus.com Investor Relations: Anthony J. Parkinson, Chief Information Officer BioNovelus, Inc. +1 888-924-6668 ext.3 AParkinson@BioNovelus.com\nSource:BioNovelus Inc.", "external_links": ["https://www.globenewswire.com/Tracker?data=yj7Y-CqsYSv476s0CP40M0w2Lkq4z8K2WuIkpW2H0bl4MPGsj7lxZtEQ9U5P3Q2oPQId5sZ4qCPGvS6LJMZ8YhTxc8EPLqZVX2B3Y6T5qj4RUP6vcLI1dNS1V1ki-oBz-JnRB-GTnqUs0a2WygVT_A==", "https://bionovelus.com/quarterly-reports/", "https://resource.globenewswire.com/Resource/Download/30c69836-56b7-474b-80d5-aa89a44d2b23", "https://resource.globenewswire.com/Resource/Download/518b3e31-9c19-4976-a8b4-0516b9b80151", "https://www.globenewswire.com/NewsRoom/AttachmentNg/49b20a92-3ced-47cf-8efc-177a8b57a55a"], "published": "2018-05-15T04:45:00.000+03:00", "crawled": "2018-05-15T07:12:15.000+03:00", "highlightTitle": ""}